A gut microbiota score predicting acute graft‐versus‐host disease following myeloablative allogeneic hematopoietic stem cell transplantation

Lijie Han,Ke Zhao,Yuanyuan Li,Haohao Han,Lizhi Zhou,Ping Ma,Zhiping Fan,Hui Sun,Hua Jin,Zhongxing Jiang,Qifa Liu,Jie Peng
DOI: https://doi.org/10.1111/ajt.15654
IF: 9.369
2019-12-12
American Journal of Transplantation
Abstract:<p>Although studies have reported that intestinal microbiota is associated with aGVHD, they lacked a satisfactory method for predicting aGVHD. We collected stool and blood samples at day 15 post‐transplantation from 150 patients, who underwent myeloablative conditioning allogeneic hematopoietic stem cell transplantation (allo‐HSCT) from two centers. Stool microbiota was detected by 16S rRNA gene sequencing, inflammatory factors and T lymphocyte were detected by multiplex immunoassays and flow cytometry respectively. A gut microbiota score (GMS) from a LASSO (least absolute shrinkage and selection operator) model was developed and validated to predict aGVHD. In the discovery cohort, the GMS could predict II‐IV aGVHD (area under the ROC curve, AUC = 0.904, <i>P</i> &lt; 0.0001). Furthermore, the validation model was consistent with the discovery set (AUC = 0.887, <i>P</i> &lt; 0.0001). Treg/Th17 cells ratio in the low GMS subgroup was higher compared with the high GMS (<i>P</i> = 0.012), and the validation set consisted with the discovery set (<i>P</i> = 0.003). In addition, high cytokine levels were associated with high GMS. In conclusions, the GMS at neutrophil engraftment could predict aGVHD, and it was a potential and novel method. The GMS was associated with the inflammatory factor and Treg/Th17 balance.</p>
What problem does this paper attempt to address?